Model smarter, not harder: how Phoenix Cloud puts the science back at the center of modeling
Certara Model Designer brings cloud based pharmacometric modeling to your browser, with a curated model…
Arjen BosJuly 16, 2026
Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis
Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…
CertaraJuly 16, 2026
Dosimetry for Radiopharmaceutical Therapy: From Measurement to Dose Justification
Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…
Hunter Stephens, PhDJuly 7, 2026
5 Key Principles of Modern PK/PD in 2026
Explore other Phoenix solutions to enhance your PK/PD workflow and discover how Phoenix helps you…
CertaraJune 30, 2026
63 Runs and No Convergence: When RsNLME Succeeded Where Other PK/PD Solutions Couldn’t
After 63 failed runs on a 16-ODE neutropenia model, RsNLME achieved PK/PD convergence on the…
Stephen DuffullJune 23, 2026
Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling
Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…
CertaraJune 22, 2026
Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices
Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…
CertaraJune 22, 2026
Model Smarter, Not Harder: Introducing Model Designer
Watch Model Designer on demand: Certara's browser based tool for faster NLME model discovery, configuration,…
CertaraJune 10, 2026
Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study
Download this poster to see how Certara used quantitative systems pharmacology (QSP) to translate ¹⁷⁷Lu-PSMA-617…
CertaraJune 9, 2026
